Management of extrapulmonary sarcoidosis: challenges and solutions
Khalid Al-Kofahi(University of Kansas), Nadera Sweiss(University of Illinois Chicago), Shanti Virupannavar(University of Illinois Chicago), Ian C Chang(Michigan State University), Robert P. Baughman(University of Cincinnati), Naim Qaqish(Nutrition Sciences (Belgium)), Mehdi Mirsaeidi(Jacksonville University), Peter Korsten(Universitätsmedizin Göttingen), Lesley Ann Saketkoo(Tulane University), Christian Ascoli(University of Illinois Chicago)
Cited by 78
Related Papers
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis
|Critical Care Medicine|1997|863
ERS clinical practice guidelines on treatment of sarcoidosis
|European Respiratory Journal|2021|579
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
|PubMed|2014|505
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
PD-1 up-regulation on CD4 <sup>+</sup> T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production
|Science Translational Medicine|2018|364